DEXCOM INC. DL-,001/ US2521311074 /
2024-05-27 8:49:12 AM | Chg. +0.90 | Volume | Bid8:49:12 AM | Ask8:49:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
117.00EUR | +0.78% | - Turnover: - |
117.00Bid Size: - | 117.88Ask Size: - | 46.72 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.